ONO-4685

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ONO-4685, covering 2024-05-03 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma [Phase 1]